Moreno CS

ORCID: 0000-0002-5582-0028 · 2 papers in corpus · active 2014-2020
2020
The JNK inhibitor AS602801 Synergizes with Enzalutamide to Kill Prostate Cancer Cells In Vitro and In Vivo and Inhibit Androgen Receptor Expression.
Translational oncology ·doi:10.1016/j.tranon.2020.100751

In our previous study, we observed that androgen deprivation therapy (ADT) may induce a compensatory increase in MAPK or JNK signaling. Here, we tested the effects of the MEK inhibitors PD0325901 and GSK1120212, ERK1/2 inhibitor GDC-0994, a…

2014
Assessing needs and assets for building a regional network infrastructure to reduce cancer related health disparities.
Evaluation and program planning ·doi:10.1016/j.evalprogplan.2013.12.003

Significant cancer health disparities exist in the United States and Puerto Rico. While numerous initiatives have been implemented to reduce cancer disparities, regional coordination of these efforts between institutions is often limited. T…